Regulatory Hurdles Facing Psychedelics
Market introduction of psychedelics as a therapy looks promising. However, policy and regulatory issues concerning the drug class still exist.
Articles
Scientists Engineer E. Coli to Produce Psilocybin
This is the first time psilocybin has been produced from a prokaryotic organism.
Usona Institute Beginning Phase 2 Clinical Trials Using Psilocybin to Treat Major Depressive Disorder
Enrollment of study volunteers is expected to start within the next two months.
The State of the Art of Psilacetin (4-AcO-DMT)
Psilacetin is easier and less expensive to make than psilocybin, but much of its pharmacology is unknown.
DMT: The Biosynthesis Debate
New research provides insight into the debate centered around the brain's capacity to synthesize DMT endogenously.
2014 Study Shows Psilocybin Changes Communication Patterns
A 2014 study showed that psilocybin opens up communication between areas of the human brain that don't normally talk to each other.
Johns Hopkins Medicine Opens Center for Psychedelic and Consciousness Research
The center is the first of its kind in the US and will propel psychedelic research to a new level.
Johns Hopkins Starts Psilocybin Clinical Trial to Treat Anorexia Nervosa
Anorexia has phenomenological parallels to anxiety and addiction, both of which have been shown to improve with psilocybin-assisted interventions.
Why Do Magic Mushrooms Cause Nausea?
The evidence points to several possibilities. It could be psilocybin or a combination of factors.
Psychedelics and Women’s Health
More and more women are self-treating with psychedelics to relieve their symptoms.